Finding the ideal disinfection agent
7 August 2020Regular disinfection can help to limit the spread of viral infections such as COVID-19, but only if carried out appropriately, write Xian Jun Loh and colleagues.
ARCHIVES
153 results for "Features"
Taming abnormal blood vessel growth
29 July 2020Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.
The fast track to Fortitude
27 July 2020In a display of scientific willpower, A*STAR researchers developed and deployed the COVID-19 diagnostic Fortitude Kit within weeks of the virus reaching Singapore’s shores.
The Curiox case for better cell analysis
25 June 2020Curiox Biosystems, an A*STAR spin-off company, specializes in automated and quantitative cell analysis. Its CEO, Namyong Kim, shares the story of the company’s success.
Shining a light on quantum materials
12 June 2020By manipulating light to reveal unusual properties of quantum materials, Justin Song is ushering in a new age of quantum devices.
Leading the way in microRNA technology
21 May 2020After a decade of research and innovation, homegrown biotech company MiRXES can now call themselves a global leader in developing microRNA-based technology to solve real-world issues.
What we know about COVID-19 and how it can be treated
14 May 2020Lisa F. P. Ng, a leading infectious disease expert on infection and immunity, shares how her team’s prior experience has helped them quickly understand the nature of SARS-CoV-2, the virus that causes COVID-19.
Innovation at the speed of light
8 May 2020By combining the expertise in silicon wafer manufacturing with the emerging field of integrated photonics, Advanced Micro Foundry is helping its customers get the best of both worlds.
Chip design with AI inside
24 April 2020A machine learning algorithm that takes the trial and error out of chip design could help us extend Moore’s Law for a few more years.
Defying convention in cancer drug discovery
2 April 2020Just because a molecular target resides inside a cancer cell does not mean that it cannot be targeted by antibodies, says Qi Zeng, founder of A*STAR spin-off company Intra-ImmuSG.
Rethinking breast cancer risk
31 March 2020Jingmei Li is developing a risk scoring system for breast cancer that could help clinicians formulate better screening programs to catch the disease in its early stages.
Asian genomes in the spotlight
24 February 2020A*STAR scientists have created the world’s largest multi-ethnic Asian genetic database to further biomedical research and shed light on the origins of three major ethnic groups in the region.
Designing today’s cities for tomorrow’s challenges
24 February 2020Cities of the future must brace for the impacts of climate change. Here’s how an integrated environmental modeling tool developed by A*STAR is helping Singapore’s urban planners rise to the challenge.
Page
